oxazoles has been researched along with Black Fever in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Coelho, F; Ferreira, LLG; Teles, HR; Valli, M | 1 |
| Ballard, J; Be, C; Berman, A; Biggart, A; Bursulaya, B; Caridha, D; Chen, YL; Chianelli, D; Davis, LC; Eggimann, FK; Gao, MY; Gibney, M; Glynne, RJ; Groessl, T; Hein, A; Jiricek, J; Johnson, K; Khare, S; Kreishman-Deitrick, M; Lai, YH; Lerario, I; Liang, F; Liu, X; Luneau, A; Mathison, CJN; Molteni, V; Nagle, A; Pybus, B; Rao, SPS; Richmond, W; Rudewicz, PJ; Sciotti, RJ; Shapiro, M; Smith, J; Spraggon, G; Srinivas, H; Supek, F; Thompson, C; Tuntland, T; Wiesmann, C; Xie, Y; Yeh, V | 1 |
| Auer, JL; Fairlamb, AH; Norval, S; Osuna-Cabello, M; Patterson, S; Read, KD; Simeons, FR; Stojanovski, L; Wyllie, S | 1 |
| Bhaduri, A; Mukherjee, T; Roy, K | 1 |
4 other study(ies) available for oxazoles and Black Fever
| Article | Year |
|---|---|
Hierarchical Clustering and Target-Independent QSAR for Antileishmanial Oxazole and Oxadiazole Derivatives.
Topics: Antiprotozoal Agents; Cluster Analysis; Humans; Leishmaniasis, Visceral; Oxadiazoles; Oxazoles; Quantitative Structure-Activity Relationship | 2022 |
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases.
Topics: Animals; Antiprotozoal Agents; Dogs; Humans; Leishmania donovani; Leishmania major; Leishmaniasis, Visceral; Liver; Macaca fascicularis; Mice; Mice, Inbred BALB C; Oxazoles; Proteasome Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Triazoles | 2020 |
The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Antitubercular Agents; Biotransformation; Disease Models, Animal; Drug Administration Schedule; Drug Dosage Calculations; Drug Repositioning; Female; Hormesis; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Nitroimidazoles; Oxazoles; Parasitic Sensitivity Tests; Treatment Outcome | 2016 |
Acivicin: a highly active potential chemotherapeutic agent against visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cells, Cultured; Enzyme Activation; Isoxazoles; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Oxazoles | 1990 |